177 related articles for article (PubMed ID: 12203942)
1. Neurovascular disease, antioxidants and glycation in diabetes.
Dickinson PJ; Carrington AL; Frost GS; Boulton AJ
Diabetes Metab Res Rev; 2002; 18(4):260-72. PubMed ID: 12203942
[TBL] [Abstract][Full Text] [Related]
2. Reducing the incidence of foot ulceration and amputation in diabetes.
Bartus CL; Margolis DJ
Curr Diab Rep; 2004 Dec; 4(6):413-8. PubMed ID: 15539004
[TBL] [Abstract][Full Text] [Related]
3. A foot care program for diabetic unilateral lower-limb amputees.
Carrington AL; Abbott CA; Griffiths J; Jackson N; Johnson SR; Kulkarni J; Van Ross ER; Boulton AJ
Diabetes Care; 2001 Feb; 24(2):216-21. PubMed ID: 11213868
[TBL] [Abstract][Full Text] [Related]
4. Lowering the risk of neuropathy, foot ulcers and amputations.
Boulton AJ
Diabet Med; 1998; 15 Suppl 4():S57-9. PubMed ID: 9868994
[TBL] [Abstract][Full Text] [Related]
5. Alternative therapeutic principles in the prevention of microvascular and neuropathic complications.
Gries FA
Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S201-7. PubMed ID: 8529515
[TBL] [Abstract][Full Text] [Related]
6. [Interdisciplinary treatment of diabetic foot syndrome].
Eckardt A; Kraus O; Küstner E; Neufang A; Schmiedt W; Meurer A; Schöllner C; Schadmand-Fischer S
Orthopade; 2003 Mar; 32(3):190-8. PubMed ID: 12647039
[TBL] [Abstract][Full Text] [Related]
7. Medical strategies to reduce amputation in patients with type 2 diabetes.
Malik RA; Tesfaye S; Ziegler D
Diabet Med; 2013 Aug; 30(8):893-900. PubMed ID: 23445087
[TBL] [Abstract][Full Text] [Related]
8. A model to estimate cost-savings in diabetic foot ulcer prevention efforts.
Barshes NR; Saedi S; Wrobel J; Kougias P; Kundakcioglu OE; Armstrong DG
J Diabetes Complications; 2017 Apr; 31(4):700-707. PubMed ID: 28153676
[TBL] [Abstract][Full Text] [Related]
9. Statins may be useful in diabetic foot ulceration treatment and prevention.
Gulcan E; Gulcan A; Erbilen E; Toker S
Med Hypotheses; 2007; 69(6):1313-5. PubMed ID: 17499447
[TBL] [Abstract][Full Text] [Related]
10. Assessing the feet of patients with diabetes.
Lavery L; Gazewood JD
J Fam Pract; 2000 Nov; 49(11 Suppl):S9-16. PubMed ID: 11093554
[TBL] [Abstract][Full Text] [Related]
11. Role of advanced glycation end products in diabetic neuropathy.
Sugimoto K; Yasujima M; Yagihashi S
Curr Pharm Des; 2008; 14(10):953-61. PubMed ID: 18473845
[TBL] [Abstract][Full Text] [Related]
12. The Diabetic Foot as a Proxy for Cardiovascular Events and Mortality Review.
Dietrich I; Braga GA; de Melo FG; da Costa Silva Silva ACC
Curr Atheroscler Rep; 2017 Oct; 19(11):44. PubMed ID: 28971322
[TBL] [Abstract][Full Text] [Related]
13. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study.
Gershater MA; Löndahl M; Nyberg P; Larsson J; Thörne J; Eneroth M; Apelqvist J
Diabetologia; 2009 Mar; 52(3):398-407. PubMed ID: 19037626
[TBL] [Abstract][Full Text] [Related]
14. Protective role of sulphoraphane against vascular complications in diabetes.
Yamagishi S; Matsui T
Pharm Biol; 2016 Oct; 54(10):2329-39. PubMed ID: 26841240
[TBL] [Abstract][Full Text] [Related]
15. [Diabetic peripheral neuropathy: international guidelines for prevention, diagnosis, and treatment].
van Dam PS; Valk GD; Bakker K
Ned Tijdschr Geneeskd; 2000 Feb; 144(9):418-21. PubMed ID: 10719545
[TBL] [Abstract][Full Text] [Related]
16. [Diabetic foot syndrome].
Karrer S
Hautarzt; 2011 Jul; 62(7):493-503. PubMed ID: 21681544
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study.
Boyko EJ; Ahroni JH; Stensel V; Forsberg RC; Davignon DR; Smith DG
Diabetes Care; 1999 Jul; 22(7):1036-42. PubMed ID: 10388963
[TBL] [Abstract][Full Text] [Related]
18. Foot problems in diabetes.
Slovenkai MP
Med Clin North Am; 1998 Jul; 82(4):949-71. PubMed ID: 9706128
[TBL] [Abstract][Full Text] [Related]
19. Effects of protein kinase Cbeta inhibition on neurovascular dysfunction in diabetic rats: interaction with oxidative stress and essential fatty acid dysmetabolism.
Cameron NE; Cotter MA
Diabetes Metab Res Rev; 2002; 18(4):315-23. PubMed ID: 12203947
[TBL] [Abstract][Full Text] [Related]
20. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers.
Adler AI; Boyko EJ; Ahroni JH; Smith DG
Diabetes Care; 1999 Jul; 22(7):1029-35. PubMed ID: 10388962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
